160 related articles for article (PubMed ID: 34496493)
1. [Inflammatory myofibroblastic tumors of the urinary bladder: a clinicopathological study of ten cases].
Zhang HZ; Wang SY; Dong L; Yang XQ; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1024-1028. PubMed ID: 34496493
[No Abstract] [Full Text] [Related]
2. [Clinicopathologic features and immunophenotype of pseudosarcomatous myofibroblastic proliferation of urinary bladder].
Zhang YH; Zhang XR; Yu J; Li HL
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):585-590. PubMed ID: 30107662
[No Abstract] [Full Text] [Related]
3. [Clinicopathological features of inflammatory myofibroblastic tumor].
Zhu Y; Ding Y; Song GX; Li X; Ding R; Fan QH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):194-200. PubMed ID: 33677881
[No Abstract] [Full Text] [Related]
4. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.
Choi E; Williamson SR; Montironi R; Zhang S; Wang M; Eble JN; Grignon DJ; Lopez-Beltran A; Idrees MT; Baldridge LA; Scarpelli M; Jones CL; Wang L; MacLennan GT; Osunkoya AO; Cheng L
Histopathology; 2015 Jul; 67(1):20-38. PubMed ID: 25406945
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
[TBL] [Abstract][Full Text] [Related]
6. [Inflammatory myofibroblastic tumor of bladder: a clinicopathologic study of five cases].
Sun K; Wang ZM; Xu LJ; Teng XD; Yao HT; Ren GP
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):605-8. PubMed ID: 18070449
[TBL] [Abstract][Full Text] [Related]
7. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
[No Abstract] [Full Text] [Related]
8. [Clinical and molecular pathological features of uterine inflammatory myofibroblastic tumor].
Zhang Y; Dong W; Li SX; Zhao JJ; Du B
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1020-1023. PubMed ID: 34496492
[No Abstract] [Full Text] [Related]
9. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
Yu L; Liu J; Lao IW; Luo Z; Wang J
Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
[TBL] [Abstract][Full Text] [Related]
12. A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
Inamura K; Kobayashi M; Nagano H; Sugiura Y; Ogawa M; Masuda H; Yonese J; Ishikawa Y
Hum Pathol; 2017 Nov; 69():96-100. PubMed ID: 28504207
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature.
Freeman A; Geddes N; Munson P; Joseph J; Ramani P; Sandison A; Fisher C; Parkinson MC
Mod Pathol; 2004 Jul; 17(7):765-71. PubMed ID: 15105807
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of gastric plexiform fibromyxoma].
Hu GM; Chen HP; Liu QY; Shi XC; Wu HF; Feng YK; Ren JL; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):258-262. PubMed ID: 29690664
[No Abstract] [Full Text] [Related]
15. [Clinicopathologic features of extrapulmonary inflammatory myofibroblastic tumor].
Li H; Shen Q; Xia Q; Shi S; Zhang R; Yu B; Ma H; Lu Z; Wang X; He Y; Zhou X; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):370-4. PubMed ID: 25208985
[TBL] [Abstract][Full Text] [Related]
16. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.
Tsuzuki T; Magi-Galluzzi C; Epstein JI
Am J Surg Pathol; 2004 Dec; 28(12):1609-14. PubMed ID: 15577680
[TBL] [Abstract][Full Text] [Related]
17. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
[TBL] [Abstract][Full Text] [Related]
18. Primary round cell sarcomas of the urinary bladder with EWSR1 rearrangement: a multi-institutional study of thirteen cases with a review of the literature.
Baisakh MR; Tiwari A; Gandhi JS; Naik S; Sharma SK; Balzer BL; Sharma S; Peddinti K; Jha S; Sahu PK; Pradhan D; Geller M; Amin MB; Dhillon J; Mohanty SK
Hum Pathol; 2020 Oct; 104():84-95. PubMed ID: 32798549
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
[TBL] [Abstract][Full Text] [Related]
20. For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.
Taheri D; Zahavi DJ; Del Carmen Rodriguez M; Meliti A; Rezaee N; Yonescu R; Ricardo BF; Dolatkhah S; Ning Y; Bishop JA; Netto GJ; Sharma R
Virchows Arch; 2016 Sep; 469(3):345-50. PubMed ID: 27271275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
